In this report, we assessed the expression of TGFβ2 as it related to the prognosis of 33 different types of cancers using the independent Oncomie and GEPIA databases, revealing clear differences between tumour and normal tissue expression of TGFβ2 in many cancers. Here, TGFB2 is linked to neoplasm.